70 related articles for article (PubMed ID: 6872045)
1. [Blockade of estradiol benzoate hyperplasia of the adenohypophysis with Deprenon and lisuride - histological findings].
Dusková J; Schreiber V; Pribyl T; Jahodová J
Cesk Patol; 1983 May; 19(2):101-7. PubMed ID: 6872045
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of the dopaminergic activity of the new Czechoslovak ergoline derivate transdihydrolisuride (Tergurid Spofa) with lisuride].
Schreiber V; Jahodová J
Bratisl Lek Listy; 1986 Jan; 85(1):14-8. PubMed ID: 3955392
[No Abstract] [Full Text] [Related]
3. Nucleolar inhibition in prolactin cells after combined thyroid hormone plus lisuride treatment in estrogenized rats.
Dusková J; Schreiber V
Endocrinol Exp; 1989 Sep; 23(3):185-94. PubMed ID: 2572415
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the oestradiol-induced increase in adenohypophyseal weight and in hypothalamic and serum polyphenol oxidase activity by dopaminergic agonists.
Schreiber V; Pribyl T; Jahodová J
Physiol Bohemoslov; 1983; 32(2):117-20. PubMed ID: 6408657
[TBL] [Abstract][Full Text] [Related]
5. Interaction of perphenazine and an ergoline derivative on oestrogen-induced adenohypophyseal growth.
Schreiber V; Pribyl T
Physiol Bohemoslov; 1977; 26(1):31-8. PubMed ID: 140398
[TBL] [Abstract][Full Text] [Related]
6. AgNORs in estrogen-induced and lisuride- and thyreoidin-inhibited rat anterior pituitary hyperplasia. Computer image analysis and nonautomated AgNOR typing.
Dusková J; Povýsil C; Schreiber V
Anal Quant Cytol Histol; 1997 Feb; 19(1):55-61. PubMed ID: 9051187
[TBL] [Abstract][Full Text] [Related]
7. Lisuride, a dopamine agonist, inhibits DNA synthesis in the pituitary gland.
Burdman JA; Calabrese MT; Harcus CT; MacLeod RM
Neuroendocrinology; 1982 Oct; 35(4):282-6. PubMed ID: 7145022
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by an ergoline derivative (dopaminergic agonist) of oestradiol-induced adenohypophyseal growth and of the decrease in the hypothalamic ascorbic acid (HAA) concentration in rats.
Schreiber V; Pribyl T; Jahodová J
Physiol Bohemoslov; 1982; 31(2):97-100. PubMed ID: 6212960
[TBL] [Abstract][Full Text] [Related]
9. The role of dopamine in methylene blue-mediated inhibition of estradiol benzoate-induced anterior pituitary hyperplasia in rats.
Nedvídková J; Pacák K; Haluzík M; Nedvídek J; Schreiber V
Neurosci Lett; 2001 May; 304(3):194-8. PubMed ID: 11343835
[TBL] [Abstract][Full Text] [Related]
10. Lisuride hydrogen maleate: an ergoline with beta-adrenergic antagonist activity.
Cote T; Munemura M; Kebabian J
Eur J Pharmacol; 1979 Nov; 59(3-4):303-6. PubMed ID: 43258
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacologic arrest of lactation. Comparison of Deprenon, lisuride, terguride and mestranol].
Vido I; Cepický P
Cesk Gynekol; 1989 Nov; 54(9):654-61. PubMed ID: 2624954
[TBL] [Abstract][Full Text] [Related]
12. Influence of estradiol and other gonadal steroids on central effects of lisuride and comparable ergot derivatives.
Horowski R; Dorow R
Exp Brain Res; 1981; Suppl 3():169-81. PubMed ID: 7250244
[No Abstract] [Full Text] [Related]
13. Effect of d-6-methyl-8-ergoline-i-ylacetamide (Deprenon) on the FSH content of the pituitary in castrated female rats.
Rezábek K; Recábek K
Physiol Bohemoslov; 1976; 25(5):407-10. PubMed ID: 136001
[TBL] [Abstract][Full Text] [Related]
14. Endocrine and clinical results in administering lisuride for inhibiting lactation.
Zanagnolo VL; Pollini F; Falsetti L; Gastaldi A
Acta Eur Fertil; 1987; 18(1):21-4. PubMed ID: 3115024
[TBL] [Abstract][Full Text] [Related]
15. Action of lisuride on reserpine-induced muscular rigidity in rats after local application into the striatum, ventricular space or the spinal subarachnoid space.
Flosbach CW; Bräutigam M; Dreesen R; Herken H
Arzneimittelforschung; 1982; 32(5):488-91. PubMed ID: 7201824
[TBL] [Abstract][Full Text] [Related]
16. Changes in the concentration of adenohypophyseal prolactin and morphological manifestations in the adenohypophysis of lactating rats after administration of D-6-methyl-8-[beta-isopropylaminoethyl] ergoline-I.
Krejcí P; Marhan O; Ausková M; Rezábek K; Semonský M
Experientia; 1976 Oct; 32(10):1308-9. PubMed ID: 987925
[TBL] [Abstract][Full Text] [Related]
17. Depression of reserpine-induced muscular rigidity in rats after administration of lisuride into the spinal subarachnoid space.
Bräutigam M; Flosbach CW; Herken H
Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(2):177-9. PubMed ID: 6894183
[TBL] [Abstract][Full Text] [Related]
18. Changes in basic fibroblast growth factor coincident with estradiol-induced hyperplasia of the anterior pituitaries of Fischer 344 and Sprague-Dawley rats.
Schechter J; Weiner R
Endocrinology; 1991 Nov; 129(5):2400-8. PubMed ID: 1935774
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of prolactin secretion in rats with the ergoline derivative deprenon.
Chlebounová J; Seda M; Fingerová H; Rezábek K
Arzneimittelforschung; 1980; 30(6):956-8. PubMed ID: 7191272
[TBL] [Abstract][Full Text] [Related]
20. Effect of the ergot derivative lisuride hydrogen maleate on serum prolactin concentrations in female rats.
Gräf KJ; Neumann F; Horowski R
Endocrinology; 1976 Mar; 98(3):598-605. PubMed ID: 1261489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
